Australia yesterday hailed as “remarkable” the 1.3 percent growth in its mining-driven economy in the first three months of the year, as consumer spending rallied and business investment boomed.
The Australian Bureau of Statistics (ABS) said the quarter-on-quarter expansion, compared with an upwardly-revised 0.6 percent for the final quarter of the year, took annual growth to 4.3 percent.
Both figures overshot forecasts of 0.7 percent and 3.4 percent respectively in a performance driven by rallying consumer spending and business investment, which offset weak exports.
Australian Treasurer Wayne Swan described the data as “stunning” proof of Australia’s world-beating economic strength, with annual growth at its fastest pace since before the global financial crisis more than four years ago.
“Today’s national accounts paint an extraordinary picture of exceptional growth in the March quarter ... putting our economy in a league of its own, despite ongoing global turbulence,” Swan said of the “remarkable outcome.”
However, analysts warned against too much optimism, saying the figures were likely to be an “aberration” given the weakening in conditions since March.
“Our assessment is that it would be very dangerous to assume that this sort of growth will continue,” AMP Capital chief economist Shane Oliver said. “Sure, the mining boom has a way to go, but more timely data for April and May suggest that retailing, housing related activity, manufacturers and services sectors are continuing to struggle.”
Canberra expects growth of 3.25 percent in the 2012-2013 fiscal year and 3 percent in each of the following three years, while the Reserve Bank of Australia has tipped growth of between 2.5 percent and 3.5 percent.
Just a few years ago, the millennial generation — generally defined as those born from the early 1980s through the mid-1990s — was synonymous with youthful rebellion. However, now, as the millennials ease into early middle age, they are finding their path out of their parents’ basement to be a lot harder than it was for earlier generations. The fundamental problem is that millennials are not building wealth. The wealth of the median US household headed by someone 35 or younger has actually shrunk in inflation-adjusted terms since the mid-2000s, even as the wealth of older Americans has continued to grow. An
‘LITTLE CHOICE’: The airline said it expected only about 8,000 of its 29,000 employees to be working by next month, but hoped to have 21,000 in the next two years Qantas Airways Ltd plans to cut at least 6,000 jobs and keep 15,000 more workers on extended furloughs as Australia’s largest airline tries to survive the coronavirus pandemic. Qantas yesterday announced a plan to reduce costs by billions of dollars and raise fresh capital. The plan includes grounding 100 planes for a year or more and immediately retiring its six remaining Boeing Co 747 planes. Chief executive Alan Joyce said the airline has to become smaller as it braces for several years of much lower revenues. He said the furloughed workers faced a long interruption to their airline careers. “The actions that we’re taking
Apple Inc’s decision to stop using Intel Corp processors in its Mac computers and switching to its own chips might benefit Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and boost Taiwan’s high-tech exports, Australia and New Zealand Banking Group (ANZ) said in a note on Tuesday. The US tech giant announced the “Apple silicon” initiative at its annual Worldwide Developers’ Conference, which started on Monday. The company said the first Mac powered by its own chips would debut by the end of this year and all product lines might shift to the new architecture in the next two years. TSMC is likely to
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price